Early‍ Diagnosis Saves Lives, Says Brent Sancho

Brent sancho, who represented Trinidad⁢ and Tobago at the 2006 FIFA World Cup in Germany, is publicly‍ sharing his prostate‌ cancer journey to advocate for increased⁢ awareness and testing.Sancho, 47, discovered he had‍ an​ aggressive form of prostate cancer after experiencing elevated PSA levels. An MRI and subsequent biopsy confirmed the ‌diagnosis.

“A year ago, almost to the day – ⁢December 6th, to be exact – I had a radical prostatectomy,‌ and I thought that was it,” Sancho stated. “but then,six months ⁣later,my PSA​ was again on the rise,and another scan showed that my prostate cancer⁣ had spread to my pelvic bone. I started on medication ‌shortly⁤ after and just this morning ⁤completed⁤ seven and a half weeks of radiation therapy. the journey continues.”

UK Screening Guidelines under Scrutiny

Sancho’s advocacy⁤ comes as the UK National Screening Committee (UKNSC) recently issued a draft proposal against routine prostate cancer screening for most ⁢men in the UK. The UKNSC advises the government on screening⁢ programs. The draft ​recommendation, released last week, has sparked ⁣debate among medical professionals and patient advocacy groups. The UK National Screening Committee is responsible for ⁢evaluating the effectiveness of screening programs.

Despite the UKNSC’s position, Sancho strongly urges anyone with concerns to proactively seek testing. He emphasizes that early detection is crucial for successful treatment.

Who Should Get Tested and when?

Medical guidelines generally recommend that ‌men over the age of 50 discuss PSA (prostate-specific antigen) testing with ​their doctors. However, Sancho highlights that for men of African descent, this age should be lowered to 40 due to a substantially⁣ higher⁢ risk of developing and dying ‌from prostate cancer. ⁢ The American Cancer Society ⁤ notes ​that African American men are more likely to develop prostate cancer and at ⁢a younger​ age than white men.

Sancho stresses the importance ‍of advocating for ‍oneself, even in healthcare systems where PSA tests aren’t routinely ⁣encouraged. “If you’re somewhere like the UK or ⁢somewhere else where PSA tests aren’t encouraged, you have got to insist,” he said.

Family History isn’t Always a Reliable Indicator

Sancho also points out that‍ a ⁣lack of family history of cancer doesn’t guarantee immunity. He underwent genetic testing, wich revealed no cancer-related ‍traits in ​his immediate family. However, his experience demonstrates that even without a genetic predisposition, individuals can still develop the disease. “Having​ a history of cancer in the family doesn’t matter.I ​had genetic testing ⁤done and it⁢ showed no traits in my family, yet ‍this year would show that, without⁤ going⁣ into‍ too much​ detail, even‌ that didn’t exclude everybody in‍ my immediate family.”

Disproportionate Impact on Caribbean Men

Sancho specifically addressed the Caribbean community, noting that Caribbean men experience the ⁤highest mortality rate from prostate cancer globally. Research published in the Journal of the National Medical Association confirms ⁣the disproportionately high incidence and mortality rates‌ of prostate⁢ cancer‍ among men of African descent, including those ‍of⁣ Caribbean origin.

“The‍ highest rate of‍ prostate cancer mortality is in Caribbean men, so if you allow me ⁤to speak to my community, my people.‌ Please, go get tested, know your PSA, track its history. Prostate cancer is survivable if​ caught​ early enough. Ther are treatments ⁣for‌ it. Testing saves lives. It saved mine.”

Understanding PSA Testing

PSA is a protein produced‍ by the prostate gland. Elevated levels in the blood can indicate prostate ⁤cancer,